Anti Diabetic Medicine

Approx. Rs 21,000 / BoxGet Latest Price

Product BrochureProduct Details:

MOUNJARO 5MG (TIRZEPATIDE) KWIKPEN is an innovative, once-weekly injectable treatment used primarily for type 2 diabetes management. It helps improve blood sugar levels and supports significant weight reduction. Its dual-action formula sets it apart in modern metabolic therapy.

Product Full Description:

MOUNJARO 5MG (TIRZEPATIDE) KWIKPEN is a GLP-1 and GIP receptor agonist used for glycemic control in adults with type 2 diabetes. Its unique mechanism targets two key hormone pathways to help regulate insulin, reduce appetite, and promote weight loss. The pre-filled KwikPen ensures easy, accurate, and convenient self-injection. Each pen contains a single 5mg dose of tirzepatide and is designed for once-weekly use under medical guidance.

Usage Instructions:

1. Wash your hands and inspect the pen before use.

2. Select an injection site (abdomen, thigh, or upper arm).

3. Clean the site with alcohol.

4. Inject the dose once weekly, on the same day each week.

5. Dispose of the pen safely after use.

Always follow your healthcare provider’s dosing schedule.

Medicinal Advantages:

• Blood Sugar Control: Helps reduce HbA1c levels effectively in type 2 diabetes patients.

• Weight Management: Shown to significantly support weight loss through appetite regulation.

• Cardiometabolic Health: May improve overall cardiovascular risk markers.

• Dual Hormonal Action: Unique dual-incretin therapy (GLP-1 & GIP) for superior outcomes.

• User-Friendly Delivery: Pre-filled, ready-to-use pen for hassle-free self-administration.

Mechanism of Action:

MOUNJARO 5MG (TIRZEPATIDE) mimics two natural gut hormones—GLP-1 and GIP. These hormones increase insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite. This dual-hormone targeting enhances glucose control and encourages weight loss more effectively than single-action GLP-1 medications.

Off-Label Uses:

While primarily used for type 2 diabetes, MOUNJARO 5MG is being researched and used off-label for:

• Obesity in non-diabetics

• Polycystic Ovary Syndrome (PCOS)

• Prediabetes management

• Metabolic syndrome

These uses should be under specialist guidance.

Expert Advice:

• Always take the medication at the same time weekly.

• Do not skip doses; set a reminder if needed.

• Consult your healthcare provider before adjusting the dose.

• Monitor your blood sugar regularly.

• Combine with a balanced diet and physical activity for best results.

Precautions:

1. Not for Type 1 Diabetes – This medication is not suitable for patients with type 1 diabetes or diabetic ketoacidosis.

2. Avoid During Pregnancy – Safety in pregnancy has not been established; consult your doctor if you are pregnant or planning.

3. Thyroid Concerns – Use cautiously if you have a personal or family history of thyroid tumors or medullary thyroid carcinoma.

FAQs:

Q1: What is MOUNJARO 5MG used for?
A: It is primarily used to improve blood sugar control in adults with type 2 diabetes and to support weight loss.

Q2: Is MOUNJARO suitable for non-diabetics?
A: While it is approved for diabetes, doctors may prescribe it off-label for obesity or metabolic disorders.

Q3: How often should I take MOUNJARO?
A: It is administered once a week, on the same day each week.